Search results

  1. D

    DNDN, 1 month from FDA approval

    The chances of it not passing is pretty slim. It would be a high risk trade. But with high risk comes high rewards. If it doesn't pass this stock will crash, may be to $5. A greater likely hood is a delay due to manufacturing verifications. In that case the stock is not going to drop to 25...
  2. D

    Are writing options profitable?

    I do most of the time.
  3. D

    DNDN, 1 month from FDA approval

    FDA anouncement is May first but could come sooner. Debate is how much of the news is already built into the price. It is near $40 and was under 4.00 last year. Since it didn't pass last time I think there is enough doubt that there is room for it to go up. Market cap is already over 5...
  4. D

    DNDN, 1 month from FDA approval

    I had stock and options in this company back in 2007 and after the FDA Advisory committee gave it's thumbs up the same euphoric percentages was being said by stock holders. No way it can't pass if their own advisory committee gave it a go. Well it didn't pass. I took a big loss. I am in it...
  5. D

    Are writing options profitable?

    I sell both calls and puts. When I sell calls it is mostly covered calls and puts can be naked or I will sell spreads to minimize my losses. You make money most of the time, I would say 80% or more. The problem is you can make one dollar on an option contract 4 consecutive times then lose...
Back
Top